Background/Aims: Prostate cancer is one of the most common cancers for males worldwide, and it is prone to show the metastatic foci in lymph node and bone with high mortality. To date, the potential mechanism and the corresponding biomarkers for metastatic prostate cancer are still lacking. Hence, our study aims to clarify the mechanism of prostate cancer progression and identify the useful biomarkers for metastatic prostate cancer. Methods: The proteins and network tightly associated with tumor metastasis were identified using quantitative proteomics. Furthermore, the mRNA level of differential expressed proteins were confirmed using qRT-PCR, and the functional cluster analysis was performed using String and Cytoscape. Results: Totally, ou...
International audience(1) Background: Prostate cancer (PCa) is characterized by high heterogeneity. ...
Molecular alterations in the prostate cancer proteome mediate the functional and phenotypic transfor...
Despite advances in molecular medicine, genomics, proteomics and translational research, prostate ca...
SummaryMolecular profiling of cancer at the transcript level has become routine. Large-scale analysi...
Purpose: Bone is the most predominant site of distant metastasis in prostate cancer, and patients ha...
Prostate cancer (PCa) is the second most frequently diagnosed cancer and the fifth leading cause of ...
Prostate cancer (PCa) is the second most frequently diagnosed cancer and the fifth leading cause of ...
A major challenge in the management of patients with prostate cancer is identifying those individual...
Early detection of prostate cancer is problematic due to the lack of a marker that has high diagnost...
Prostate cancer (PCa) is the second most commonly diagnosed malignancy in men in the Western world a...
A major challenge in the management of patients with prostate cancer is identifying those individual...
Prostate cancer is the second most frequent cancer of men worldwide. While the genetic landscapes an...
Patients with metastatic prostate cancer (PCa) have a poorer prognosis than patients with organ-conf...
Background: The problem of prostate cancer progression to androgen independence has been extensively...
International audienceBackground: Prostate cancer is a major public health issue, mainly because pat...
International audience(1) Background: Prostate cancer (PCa) is characterized by high heterogeneity. ...
Molecular alterations in the prostate cancer proteome mediate the functional and phenotypic transfor...
Despite advances in molecular medicine, genomics, proteomics and translational research, prostate ca...
SummaryMolecular profiling of cancer at the transcript level has become routine. Large-scale analysi...
Purpose: Bone is the most predominant site of distant metastasis in prostate cancer, and patients ha...
Prostate cancer (PCa) is the second most frequently diagnosed cancer and the fifth leading cause of ...
Prostate cancer (PCa) is the second most frequently diagnosed cancer and the fifth leading cause of ...
A major challenge in the management of patients with prostate cancer is identifying those individual...
Early detection of prostate cancer is problematic due to the lack of a marker that has high diagnost...
Prostate cancer (PCa) is the second most commonly diagnosed malignancy in men in the Western world a...
A major challenge in the management of patients with prostate cancer is identifying those individual...
Prostate cancer is the second most frequent cancer of men worldwide. While the genetic landscapes an...
Patients with metastatic prostate cancer (PCa) have a poorer prognosis than patients with organ-conf...
Background: The problem of prostate cancer progression to androgen independence has been extensively...
International audienceBackground: Prostate cancer is a major public health issue, mainly because pat...
International audience(1) Background: Prostate cancer (PCa) is characterized by high heterogeneity. ...
Molecular alterations in the prostate cancer proteome mediate the functional and phenotypic transfor...
Despite advances in molecular medicine, genomics, proteomics and translational research, prostate ca...